Cloud Banner

Pharmaceutical

Image

North America Active Pharmaceutical Ingredients (API) Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Active Pharmaceutical Ingredients (API) Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 3.5999999999999996% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 65951.06 Million
Diagram Market Size (Forecast Year) USD 87662.20 Million
Diagram CAGR 3.5999999999999996%

North America Active Pharmaceutical Ingredients (API) Market, By Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application) – Industry Trends and Forecast to 2030.

North America Active Pharmaceutical Ingredients (API) Market Analysis and Size

According to the World Health Organization (WHO), cardiovascular diseases are the most significant cause of death worldwide, resulting in the deaths of 17.9 million people each year. The active pharmaceutical ingredient (API) is the substance that makes medicine work. API is a component of any medicine that generates the desired effects. Drugs are frequently made up of multiple ingredients. The API is the most important component. Excipients are other components that must be biologically innocuous and typically form a changing fraction of the medication composition. Formulation refers to optimizing and composing the mixture of components used in medicine.

Data Bridge Market Research analyses that the North America active pharmaceutical ingredients (API) market which was USD  65,951.06 million in 2022, is expected to reach USD  87,662.20 million by 2030, and is expected to undergo a CAGR of 3.6% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Active Pharmaceutical Ingredients (API) Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

Dr. Reddy's Laboratories Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Aurobindo Pharma (India), Sanofi (France), Lupin (India), Cipla Inc. (U.S.), BASF SE (Germany), Merck KGaA (Germany), Novo Nordisk A/S (Denmark), AbbVie Inc. (U.S.), Alembic Pharmaceuticals Limited (India), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Ireland), Alkem Labs (India), Saneca Pharmaceuticals (Slovakia), Jubilant Pharmova Limited (India), Neuland Laboratories Ltd (India)

Market Opportunities

  • Highly potent active pharmaceutical ingredients
  • Increase in the number of research and development activities

Market Definition

The biological/synthetic active component of a final pharmaceutical product is an active pharmaceutical ingredient (API). Chemical synthesis, recombinant DNA, fermentation, isolation, and natural source recovery are popular API production methods. An API in a drug is used to treat, diagnose, mitigate, or prevent human health problems. It also directly influences the body's physiological functioning, restoring, correcting, or changing them. API has a wide range of applications in the pharmaceutical sector, including oncology, CNS diseases, diabetes, neurological disorders, cardiovascular and respiratory disorders, and others.

North America Active Pharmaceutical Ingredients (API) Market Dynamics

Drivers

  • Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases such as Alzheimer's disease and others is estimated to enhance the growth of the North America active pharmaceutical ingredients (API) market. As per the Alzheimer's Association, 5.8 million people in the U.S. were living with Alzheimer's disease in 2020. This disease is the sixth biggest cause of death in the U.S., and it is more common in persons over the age of 65. This number is likely to rise to 14 million as the baby-boomer generation reaches retirement age, aggravating the situation throughout the projection period. A new case of the disease is predicted to emerge every 33 seconds by 2050.

  • Increasing Investment for Healthcare Infrastructure

Another significant factor influencing the growth rate of active North America pharmaceutical ingredients (API) market is the rising healthcare expenditure which helps in improving its infrastructure. An increase in healthcare expenditure is being driven by an increase in the number of organizations conducting activities to raise awareness about hair regrowth and treatment alternatives.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the North America active pharmaceutical ingredients (API) market. In addition, rising adoption rate of organ on chip models in drug development and rising focus on precision medicine will result in the expansion of North America active pharmaceutical ingredients (API) market.

Opportunities

  • Increase in the Number of Research and Development Activities      

The market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for market growth of active pharmaceutical ingredients (API). Increasing research and development (R&D) in the North American active pharmaceutical ingredients (API) market is a significant catalyst that is creating substantial opportunities for market growth. The surge in R&D activities is primarily driven by advancements in technology, a deeper understanding of diseases, and an escalating demand for innovative and effective pharmaceutical products.

  • Highly Potent Active Pharmaceutical Ingredients

HPAPIs (highly potent active pharmaceutical ingredients) mark a dramatic shift in how pharmaceutical companies use small molecules to offer new medicines. As a result of the change to HPAPIs, a pipeline of more effective drugs with lower doses has emerged. HPAPIs' advantages, such as their excellent efficacy, lower therapeutic dose required (due to their selective mode of action), and capacity to bind to specific receptors, can all be attributed to their growing popularity among producers and customers.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the North America active pharmaceutical ingredients (API) market growth during the forecast period of 2023 to 2030.

Restraints/Challenges

  • High cost associated with Manufacturing Processes

On the other hand, high cost high cost associated with the production process will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market's active pharmaceutical ingredients (API). Additionally, strict regulatory policies and the negative impact of COVID-19 on the supply chain will restrain and further impede the growth rate of the market during the forecast period of 2023-2030.

This North America active pharmaceutical ingredients (API) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the North America active pharmaceutical ingredients (API) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Active Pharmaceutical Ingredients (API) Market Scope

The North America active pharmaceutical ingredients (API) market is segmented on the basis of molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Molecule

  • Small Molecule
  • Large Molecule

Type

  • Innovative Active Pharmaceutical Ingredients
  • Generic Innovative Active Pharmaceutical Ingredients

Type of Manufacturer

  • Captive API Manufacturer
  • Merchant API Manufacturer

Synthesis

  • Synthetic Active Pharmaceutical Ingredients
  • Biotech Active Pharmaceutical Ingredients

Chemical Synthesis

  • Acetaminophen
  • Artemisinin
  • Saxagliptin
  • Sodium Chloride
  • Ibuprofen
  • Losartan Potassium
  • Enoxaparin Sodium
  • Rufinamide
  • Naproxen
  • Tamoxifen
  • Others

Type of Drug

  • Prescription Drugs
  • Over-the-Counter

Usage

  • Clinical
  • Research

Potency

  • Low-to-Moderate Potency Active Pharmaceutical Ingredients
  • Potent-to-Highly Potent Active Pharmaceutical Ingredient

Therapeutic Application

  • Cardiology
  • CNS and Neurology
  • Oncology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Other Therapeutic Application

North America Active Pharmaceutical Ingredients (API) Market Regional Analysis/Insights

The North America active pharmaceutical ingredients (API) market is analysed and market size insights and trends are provided by country, molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application as referenced above.

The countries covered in the North America active pharmaceutical ingredients (API) market report are U.S., Canada, and Mexico

U.S. is the dominating and fastest growing country in the region due to prevalence of manufacturers, rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Active Pharmaceutical Ingredients (API) Market Share Analysis

The North America active pharmaceutical ingredients (API) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to North America active pharmaceutical ingredients (API) market.

Some of the major players operating in the North America active pharmaceutical ingredients (API) market are:

  • Dr. Reddy's Laboratories Ltd. (India)
  • Sun Pharmaceutical Industries Ltd. (India)
  • GlaxoSmithKline plc (U.K.)
  • Pfizer Inc. (U.S.)
  • Aurobindo Pharma (India)
  • Sanofi (France)
  • Lupin (India)
  • Cipla Inc. (U.S.)
  • BASF SE (Germany)
  • Merck KGaA (Germany)
  • Novo Nordisk A/S (Denmark)
  • AbbVie Inc. (U.S.)
  • Alembic Pharmaceuticals Limited (India)
  • AstraZeneca (U.K.)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Alkem Labs (India)
  • Saneca Pharmaceuticals (Slovakia)
  • Jubilant Pharmova Limited (India)
  • Neuland Laboratories Ltd (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The North America active pharmaceutical ingredients (API) market size will be worth USD 87,662.20 million by 2030.
The growth rate of the North America active pharmaceutical ingredients (API) market is 3.6% in the forecast period by 2030.
The increasing prevalence of chronic diseases & increasing investment in healthcare infrastructure are the growth drivers of the North America active pharmaceutical ingredients (API) market.
Molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application are the factors on which the North America active pharmaceutical ingredients (API) market research is based.
Major companies in the North America active pharmaceutical ingredients (API) market are Dr. Reddy's Laboratories Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Aurobindo Pharma (India), Sanofi (France), Lupin (India), Cipla Inc. (U.S.), BASF SE (Germany), Merck KGaA (Germany), Novo Nordisk A/S (Denmark), AbbVie Inc. (U.S.), Alembic Pharmaceuticals Limited (India), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Ireland), Alkem Labs (India), Saneca Pharmaceuticals (Slovakia), Jubilant Pharmova Limited (India), Neuland Laboratories Ltd (India)
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials